ZimVie Inc

ZimVie Inc(ZIMV)股票分析

$18.990

0.000 (0.00%)收盤時

Loading chart…
High
19.000
Open
18.990
VWAP
18.99
Vol
653.57K
Mkt Cap
480.01M
Low
18.990
Amount
12.41M
EV/EBITDA, TTM
7.26

ZimVie Inc. is a global life sciences company in the dental market. It develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. It markets its products in about 50 countries.

估值指標

The current forward P/E ratio for ZimVie Inc (ZIMV) is 17.35, compared to its 5-year average forward P/E of 17.18.

Forward P/E

Fair
5Y Average P/E
17.18
Current P/E
17.35
高估
24.39
低估
9.97

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
8.25
Current EV/EBITDA
7.26
高估
11.58
低估
4.92

Forward P/S

Fair
5Y Average P/S
0.64
Current P/S
0.79
高估
0.96
低估
0.32

Alphio AI Price Scenarios for ZIMV

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ZIMV

$6.37

情境價格

B

Base

Base · 50%ZIMV

$5.50

情境價格

B

Bear

Bear · 25%ZIMV

$5.29

情境價格

Whales holding ZIMV

J

J. Goldman & Co., L.P.

+ HoldingZIMV

-1.34%

3M Return

事件時間軸

2025-10-20 (ET)

09:02:26

ZimVie confirms it has finalized its acquisition by ARCHIMED.

2025-10-10 (ET)

09:16:08

ZimVie Shareholders Give Green Light to ARCHIMED Acquisition

2025-07-25 (ET)

08:18:03

ZimVie withdraws guidance amid ARCHIMED transaction

08:07:19

ZimVie will not host withdraws guidance amid ARCHIMED transaction

2025-07-23 (ET)

17:02:29

ZimVie announces exclusive distribution agreement with Osstem Implant in China

資訊

ZIMV FAQ — answered by Alphio AI

ZimVie Inc. is a global life sciences company in the dental market. It develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to support dental tooth replacement and restoration procedures. It works to improve smiles, function, and confidence in daily life by offering comprehensive tooth replacement solutions, including dental implants, biomaterials, and digital workflow solutions. In the dental segment, its core services include designing, manufacturing and distributing dental implant systems, dental biomaterial products and digital dentistry solutions. The key products in its dental implant systems portfolio consist of TSX Implant System, Tapered Screw-Vent (TSV) Implant System, T3 Pro Implant System, T3 Implant System, OSSEOTITE Implant System, Trabecular Metal Implant System, BellaTek Patient Specific Products, GenTek Restorative Portfolio, and Encode Healing Abutment / Impression System. It markets its products in about 50 countries. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始